# Dinova, Ascendum Capital and Metronom Health launch joint venture in China

Dinova Medtech, Ascendum Capital, and Metronom Health established a joint venture in China to develop, manufacture and sell Metronom's continuous glucose monitoring system in China.

- Type: Acquisition
- Announced: 2021-05-18
- Where: Hangzhou, China
- Status: announced
- Products: continuous glucose monitoring system
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Dinova Medtech](https://endata.com/companies/55230.md) (partner)
- [Ascendum Capital](https://endata.com/companies/55231.md) (investor)
- [Metronom Health](https://endata.com/companies/55232.md) (partner)

## Sources

- [prnewswire.com](https://www.prnewswire.com/news-releases/dinova-and-metronom-health-an-innovative-glucose-monitoring-company-announces-launch-of-a-joint-venture-in-china-301293830.html), 2021-05-18: "Dinova Medtech, a highly specialized medical device innovation hub, with Ascendum Capital, a new healthcare-focused investment platform, and Metronom Health, an innovative U.S. developer of a continuous glucose monitoring (CGM) system, have established a joint venture in China."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.